Press Release: DELFI : DELFI Diagnostics to Participate in J.P. Morgan Healthcare Conference
Leader in liquid biopsy, cancer screening, and monitoring speaks at largest healthcare investment symposium BALTIMORE...
Read full article »
Delfi is a Maryland-based biotechnology company that research and develops fluid biopsy tests for the early detection of cancer.
Read more